Edition:
United States

Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

23.13USD
14 Dec 2018
Change (% chg)

$0.19 (+0.83%)
Prev Close
$22.94
Open
$22.80
Day's High
$23.40
Day's Low
$22.58
Volume
169,097
Avg. Vol
153,244
52-wk High
$46.12
52-wk Low
$19.72

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.971
Jun '18 0.00 -0.849
Mar '18 0.00 -0.739
FY 2017 Dec '17 0.00 -0.162
Sep '17 0.00 -0.881
Jun '17 0.00 -0.867
Mar '17 0.00 -0.833
FY 2016 Dec '16 0.00 -0.902
Sep '16 0.00 -0.936
Jun '16 0.00 -0.674
Mar '16 0.00 -0.498
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 11 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 8 0.00 0.00 0.00 0.00
Year Ending Dec-18 14 0.00 0.00 0.00 0.00
Year Ending Dec-19 14 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 14 -0.90 -0.79 -1.02 -0.92
Quarter Ending Mar-19 9 -0.94 -0.82 -1.04 -0.81
Year Ending Dec-18 14 -3.43 -3.06 -3.60 -3.59
Year Ending Dec-19 14 -3.86 -3.28 -4.53 -3.44
LT Growth Rate (%) 1 3.90 3.90 3.90 -1.60
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) -- 49.58 6.22
Price to Book (MRQ) 4.46 10.17 5.20
Price to Tangible Book (MRQ) 4.80 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions 91.92 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 47.89 6.50
Sales - 5 Yr. Growth Rate -- 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -28.79 75.90 23.09
EPS (TTM) vs TTM 1 Yr. Ago -78.74 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 10.06 3.44 3.10
LT Debt to Equity (MRQ) 2.39 18.69 11.49
Total Debt to Equity (MRQ) 2.48 31.36 16.03
Interest Coverage (TTM) -- -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.03 13.16
Operating Margin (TTM) -- -185.03 6.07
Operating Margin - 5 Yr. Avg. -- -126.47 8.47
Pre-Tax Margin (TTM) -- -175.80 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.63 8.71
Net Profit Margin (TTM) -- -182.53 3.12
Net Profit Margin - 5 Yr. Avg. -- -137.03 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,648,872 873,051,409
Net Income/Employee (TTM) -782,464 653,324 103,483,755
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.00 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.50 6.47 11.45
Return on Assets - 5 Yr. Avg. -- 5.54 12.50
Return on Investment (TTM) -57.99 9.01 14.96
Return on Investment - 5 Yr. Avg. -- 6.87 16.23
Return on Equity (TTM) -145.70 10.15 16.52
Return on Equity - 5 Yr. Avg. -- 8.40 17.37
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -344.14 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Audentes Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 11.49 7.64 71 98
13 Week 34.00 27.48 83 94
26 Week 60.95 48.72 85 98
52 Week 43.62 21.73 74 68
YTD 42.36 25.02 70 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 94.12%
# of Holders: 183
Total Shares Held: 40,178,905
3 Mo. Net Change: -54,391
# New Positions: 14
# Closed Positions: 21
# Increased Positions: 72
# Reduced Positions: 70
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.